Swedish Orphan Biovitrum AB (SOBIV)

222.00
+0.80(+0.36%)
  • Volume:
    217,622
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    216.60 - 223.90
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0000872095
  • S/N:307114495

SOBIV Overview

Prev. Close
221.2
Day's Range
216.6-223.9
Revenue
16.79B
Open
216.7
52 wk Range
154.1-245.4
EPS
8.49
Volume
217,622
Market Cap
65.52B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
786,534
P/E Ratio
26.13
Beta
0.37
1-Year Change
39.89%
Shares Outstanding
295,155,297
Next Earnings Date
18 Jul 2022
What is your sentiment on Swedish Orphan Biovitrum?
or
Market is currently closed. Voting is open during market hours.

Swedish Orphan Biovitrum AB News

Swedish Orphan Biovitrum AB Company Profile

Swedish Orphan Biovitrum AB Company Profile

Employees
1532
Market
Sweden

Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The Company has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others. On September 9, 2013, the Company acquired the full rights to develop and commercialize Kineret (anakinra) from Amgen, the biotechnology company based in the United States.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong BuyStrong BuyStrong BuyStrong Buy
SummarySellStrong BuyStrong BuyStrong BuyStrong Buy